UBS Group’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $2.62M | Buy |
|
|||||
|
2023
Q4 | $2.04M | Buy |
|
|||||
|
2023
Q3 | $741K | Sell |
|
|||||
|
2023
Q2 | $1.26M | Sell |
|
|||||
|
2023
Q1 | $1.47M | Sell |
|
|||||
|
2022
Q4 | $2.78M | Buy |
|
|||||
|
2022
Q3 | $758K | Sell |
|
|||||
|
2022
Q2 | $1.36M | Sell |
|
|||||
|
2022
Q1 | $3.82M | Sell |
|
|||||
|
2021
Q4 | $4.36M | Buy |
|
|||||
|
2021
Q3 | $1.04M | Buy |
|
|||||
|
2021
Q2 | $373K | Sell |
|
|||||
|
2021
Q1 | $1.84M | Buy |
|
|||||
|
2020
Q4 | $1.25M | Buy |
|
|||||
|
2020
Q3 | $1M | Buy |
|
|||||
|
2020
Q2 | $855K | Buy |
|
|||||
|
2020
Q1 | $121K | Sell |
|
|||||
|
2019
Q4 | $625K | Sell |
|
|||||
|
2019
Q3 | $1.93M | Buy |
|
|||||
|
2019
Q2 | $243K | Buy |
|
|||||
|
2019
Q1 | $182K | Sell |
|
|||||
|
2018
Q4 | $1.03M | Buy |
|
|||||
|
2018
Q3 | $202K | Sell |
|
|||||
|
2018
Q2 | $250K | Buy |
|
|||||
|
2018
Q1 | $94K | Buy |
|
|||||
|
2017
Q4 | $100K | Buy |
|